SCYNEXIS Inc. appointed Marion McCourt as a board member.
McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.
SCYNEXIS appoints director
Climate Credit Analytics: Linking climate scenarios to financial impacts
Global M&A Infographic Q1 2021
Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge
COVID-19 Impact & Recovery: Private Equity